Source: The Business Journals: St. Louis

Washington University: Washington University grants exclusive license for nasal Covid-19 vaccine

Thanks to technology developed by Washington University in St. Louis, a Philadelphia-area biotechnology company's quest to compete in the Covid-19 vaccine marketplace has taken a new twist.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Agree?
Est. Employees
10-50K
Agree?
Andrew D. Martin's photo - Chancellor of Washington University

Chancellor

Andrew D. Martin

CEO Approval Rating

71/100

Read more